Literature DB >> 2176094

DNA topoisomerases as anticancer drug targets.

E Schneider1, Y H Hsiang, L F Liu.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2176094     DOI： 10.1016/s1054-3589(08)60342-7

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  37 in total

1.  Hydropathic analysis of the free energy differences in anthracycline antibiotic binding to DNA.

Authors:  Derek J Cashman; J Neel Scarsdale; Glen E Kellogg
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

2.  Downregulation of hnRNP C1/C2 by siRNA sensitizes HeLa cells to various stresses.

Authors:  Mohammad Nazir Hossain; Michihiko Fuji; Kensuke Miki; Morio Endoh; Dai Ayusawa
Journal:  Mol Cell Biochem       Date:  2006-09-08       Impact factor: 3.396

3.  Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.

Authors:  A Das; A Dasgupta; S Sharma; M Ghosh; T Sengupta; S Bandopadhyay; H K Majumder
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

4.  An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.

Authors:  Aditi Das; Chhabinath Mandal; Arindam Dasgupta; Tanushri Sengupta; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

5.  Angiogenic patterns and their quantitation in high grade astrocytic tumors.

Authors:  Suash Sharma; Mehar C Sharma; Deepak Kumar Gupta; Chitra Sarkar
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

6.  Characterization of alkylating versus intercalating anticancer drug-induced effects on cell survival, cell cycle kinetic and morphonuclear pattern of three neoplastic cells lines growing in vitro.

Authors:  O Pauwels; R Kiss; J L Pasteels; G Atassi
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

7.  Kinetoplast maxicircle DNA replication in Crithidia fasciculata and Trypanosoma brucei.

Authors:  L R Carpenter; P T Englund
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

8.  Formation of adriamycin--DNA adducts in vitro.

Authors:  C Cullinane; S M Cutts; A van Rosmalen; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

9.  A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma.

Authors:  F Mühr-Wilkenshoff; W Hinkelbein; I Ohnesorge; K J Wolf; E-O Riecken; M Zeitz; H Scherübl
Journal:  Int J Colorectal Dis       Date:  2003-02-01       Impact factor: 2.571

Review 10.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.